Nexalis outlines 2026 plan as IRX shares jump 35% by Adam Sheldon February 17, 2026February 19, 2026 Nexalis Therapeutics Limited – formerly InhaleRx – has used its first investor presentation since formally changing […]
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026February 5, 2026
Elixinol records first underlying operating cash flow positive quarter by Adam Sheldon February 2, 2026February 3, 2026
InhaleRx locks in A$1m cap raise and reveals plans to rebrand by Adam Sheldon December 1, 2025February 21, 2026
